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Managing Peri-implantitis
FIRST EDITION

Educational Objectives
Following this unit of instruction, the practitioner should be able to:
1. Understand the etiology and presentation of peri-implantitis.
2. Discuss different methods used to manage peri-implantitis.
3. Understand the limitations of surgical and non-surgical approaches used to manage
peri-implantitis.
4. 		Recognize the importance of searching the available literature to stay current with
effective methods to manage peri-implantitis.

Introduction

D

ental implants are often offered as an option to
replace missing natural teeth. The predictability
of implants has led to increased popularity
among both clinicians and patients over the past several
decades. Implant placements worldwide have increased
exponentially and are now estimated to be about 15
million annually.1 Much attention has been given over the
past decade to inflammatory pathology occurring around
implants. Two types of peri-implant diseases have been
identified: a) peri-implant mucositis - a reversible,
inflammatory process in the peri-implant region presenting
as reddening, swelling and bleeding on probing without
loss of supporting bone,2 and; b) peri-implantitis - an

inflammatory process resulting in progressive loss of
supporting bone around the implant (Figure 1).3
There has been no consensus regarding clearly defined
criteria for peri-implantitis, with at least thirteen different
definitions being presented. There are also multiple different
classifications of the disease. One of the classification
systems (Froum and Rosen) classified peri-implantitis
into three categories based on pocket depth and bone
loss (Table 1).4 The reported prevalence of peri-implant
mucositis is 43% with a range of 19-65%. Peri-implantitis
prevalence is reported at 22% with a range of 1- 47.1%.5
The enormous range in these estimates is due to varying
case definitions, study designs and population sizes, as
well as subjects with different risk profiles.

Figure 1
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Quality Resource Guide – Managing Peri-implantitis
Peri-implantitis demands aggressive management
compared to peri-implant mucositis. Hence,
this Quality Resource Guide will focus on
peri-implantitis, its risk factors, prevention and
management.

Table 1 - Classification of Perio-Implantitis4

Risk Factors for
Peri-implantitis

T

here are a number of factors that have
been implicated in the development
of peri-implantitis; however, poor
oral hygiene leading to the development of a
pathogenic microbial biofilm or plaque is probably
the most apparent concern in most of our
patients. Incomplete plaque removal around an
implant can result initially in the development of
peri-implant mucositis.6 Peri-implant mucositis
represents the soft tissue inflammatory response
to bacterial challenge by the microbial biofilm
and is considered an important precursor for
peri-implantitis.7 As we continue to enhance
our understanding of the role for maturation of
a pathogenic biofilm in developing periodontal
disease, we are beginning to see evidence of
similar biofilm development on implant surfaces.8
Pre-existing peri-implant mucositis without
maintenance significantly increases the incidence
of peri-implantitis, demonstrating clinical
consequences of a maturing pathogenic biofilm.9
There appears to be a strong relationship between
microbiota in periodontal disease, peri-implant
disease and natural teeth. Natural teeth with
periodontal disease appear to act as a reservoir
for pathogens in partially edentulous patients
putting implants in these patients at greater risk
of peri-implantitis.10,11 Individuals with history of
periodontitis demonstrate a higher incidence of
peri-implantitis, with deeper probing depths and
increase in marginal bone loss.12 Clinicians need to
exert extra caution in the use of implant therapy for
patients with a history of periodontal disease, and
certainly in those patients with active periodontal
disease around remaining natural teeth.13
With this well-established cause and effect
relationship between poor oral hygiene and
peri-implant disease, the role for a preventive
maintenance program becomes critical to long-
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Early

PDA > 4mm (bleeding and/or suppuration on probing)B
Bone loss <25% of implant lengthC

Moderate

probing depth > 6mm (bleeding and/or suppuration on probing)B
Bone loss 25-50% of implant lengthC

Severe

probing depth > 8mm (bleeding and/or suppuration on probing)B
Bone loss >50% of implant lengthC

Probing Depth
Noted on two or more aspects of the implant.
C Measured on radiographs from the time of definitive prosthesis loading to current radiograph.
If not available, the earliest available radiograph following loading should be used.
A
B

term implant success. Often oral hygiene and
maintenance therapy may be further compromised
by complex prosthetic designs. Where possible,
both prosthetic designs and maintenance regimens
should be adjusted with these factors in mind to
enhance the possibility of long-term success.
Apart from microbial biofilm accumulation, various
other local and systemic factors have been
implicated as risk factors that increase risk of
peri-implantitis. Renvert and Quirynen examined
the available evidence and listed the following as
risk factors for peri-implantitis:14
Local Factors
• Poor hygiene
• Smoking
• History of periodontitis
• Restorative cement overflow
• Occlusal overload
• Poor restoration design
Systemic Factors
• Diabetes
• Cardiovascular diseases
Systematic reviews suggest peri-implantitis may
occur in smokers about four times as often as
non-smokers (odds ratios between 3.6-4.6).15,16
Another important local factor associated with periimplantitis is retained cement. Cement overflow
may occur during implant crown cementation and
act as foreign body, triggering inflammation. Periimplantitis is seen in 85% of implants that exhibit

incidental cement remnants.17 Implants with
cemented restorations have 3.6 times more risk
of peri-implantitis than those with screw retained
restorations.18 Unfortunately, radiographs are
unreliable in detecting excess cement and provide
little evidence of cement overflow, increasing the
need for careful clinical assessment.19 Occlusal
overload remains controversial as a risk factor
for peri-implantitis, with studies both supporting
and refuting its role in leading to peri-implantitis.
While occlusal overload remains questionable as
a causative agent, care should be given to assure
that it is minimized. 20
Peri-implantitis is most prevalent in mandibular
posterior regions and least prevalent in the
maxillary anterior region.18 Implants placed in the
maxilla have shown a rate of failure three times
higher than those placed in the mandible. 21 This
has been attributed to the poorer bone quality
in maxilla, especially in posterior regions. 22 The
bone type at specific sites may also play a role
in success of implant. All bone types, except
type 2*, have reported almost two times greater
risk for early implant failure, 23 and type 4 bone*
has shown the greatest failure rate (63%). 24

* Type 1 bone: almost the entire bone is composed
of homogenous compact bone

Type 2 bone: a thick layer of compact bone
surrounds a core of dense trabecular bone
Type 3 bone: a thin layer of cortical bone
surrounds a core of dense trabecular bone
Type 4 bone: a thin layer of cortical bone
surrounds a core of low-density trabecular bone
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Apart from local factors, systemic conditions may
also play a role in progression of peri-implantitis.
In the past, some have stated that implants were
contraindicated in diabetic patients.25 However, in
the recent years, implants have been successfully
placed in patients with poorly controlled diabetes.26
When comparing the clinical outcomes between
well and poorly controlled diabetics, little difference
was noted in prevalence rate of bleeding on probing,
however, the prevalence of bone loss was higher
in the poorly controlled group (60% vs. 45%).27
Retrospective analysis reported cardiovascular
disease as a risk factor for peri-implantitis (odds
ratio 8.7) and a high likelihood of comorbidity.6 One
of the study’s limitations was that cardiovascular
disease was self-reported, reducing the reliability
of the reported data. Overall, there is limited
data demonstrating that cardiovascular disease
affects bone loss. Other systemic factors, such
as osteoporosis and radiation therapy in head
and neck region, can affect osseointegration and
are considered as contraindications to implant
placement.
Due to multifactorial peri-implant disease model,
one should be mindful of possible correlation of
local and systemic factors. Biofilm is considered
as the primary offending factor responsible for
marginal bone loss. Hence, it is important to
establish an implant maintenance program that
is designed based upon the patient’s difficulty in
consistently removing plaque from the implant
region and the presence of other risk factors. It
should be adjusted as necessary.

Diagnostic Criteria for
Peri-implantitis

E

arly detection of peri-implant mucositis
progression results in better case
management and an increased chance
of implant survival. Peri-implant mucositis is a
reversible process. Control of local factors can help
improve clinical parameters and halt progression to
irreversible peri-implantitis.
Important diagnostic criteria for peri-implantitis
are bleeding and/or suppuration on probing,
with progressively increasing probing depths.
It is extremely important to probe the implant
region initially to establish a baseline, and then
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at each maintenance visit to detect any increases
in probing depths. As anatomic factors associated
with differing implant designs may greatly alter
what would be considered normal probing depths
in that specific circumstance, the identification of
a change from baseline probing depth serves as a
critical indicator. Healthy sulcular depths may vary
because of differences in implant systems, depth of
abutments, positioning of implant margins relative
to adjacent bone levels, as well as surgical and
loading protocols.28 Using a reference point on the
restoration, probing depth is measured from the
base of the implant sulcus to the crest of gingival
margin.29 The clinician must remember that the soft
tissue attachment to the implant differs from that to
natural teeth; lighter probing is encouraged around
dental implants than around teeth.30 There is no
evidence that the type of probe (metal or plastic)
affects probing depth assessment or has any clinical
impact on the implant surface. It is more critical to
obtain accuracy in probing than be concerned about
potential impact to the implant surface. It is also
important to consider changes in probing depths
as a consequence of marginal tissue inflammation
rather than bone loss. Given the altered soft tissue
attachment to the implant surface, inflammation
in these tissues creates greater disruption of the
tissue integrity and may allow the probe tip to
penetrate to the bone crest.31 Therefore, critical
appraisal of the probing needs to consider the
baseline measurements were most likely made in
the absence of inflammation. Alterations in probing
depths need to be considered relative to the level
of inflammation present, knowing that the latter
circumstance may better reflect the position of the
bone crest.

Treatment of
Peri-implantitis

B

oth surgical and non-surgical approaches
have been evaluated for the management
of peri-implantitis. The treatment approach
employed is determined by probing depth and
defect characteristics. A non-surgical approach
involves surface detoxification using mechanical,
chemical, lasers and antibiotic therapy (locally and/
or systemically). Surgical approaches include access
flap, as well as resective and regenerative surgical
techniques.

Non-Surgical Approaches

Implant surface detoxification is a common step
for both surgical and non-surgical approaches.
The goal of detoxification is to reduce the bacterial
load on the implant surface and render it free
of bacterial by-products. Often, detoxification is
accomplished using periodontal curettes. Curettes
used for debridement of the implant surface must
be softer than the material comprising the implant.
Traditional stainless steel curettes have higher
external hardness than titanium and will result in
scratches on the implant surface. They should not
be used on titanium implants, however they can be
safely employed if the implant is made of titanium
zirconoxide or titanium oxinitride.32 Titanium-coated
curettes are similar in hardness to titanium implants
and minimize scratching of the implant surface.33
Non-metal curettes can successfully remove
biofilm from implant and abutment surfaces, and
are recommended for titanium implants.34 They are
available as plastic, carbon, resin-reinforced and
resin-unreinforced. Ultrasonic scalers may also be
used to detoxify the implant surface. An ultrasonic
scaler with a metal tip has been shown to eliminate
bacteria and irregularities from an implant surface
more efficiently than one using a plastic tip. Also,
use of the plastic tip resulted in same surface
irregularities as using the metal tip.35
Air-powder abrasive polishing has been shown
to be effective in biofilm removal from an implant
surface. Air abrasives containing glycine powder, as
opposed to those comprised of sodium bicarbonate
powder, are recommended due to effective biofilm
removal without any damaging effects on hard and
soft tissues.36 Detoxification of the implant surface
may also be achieved with application of hydrogen
peroxide, EDTA, chlorhexidine, citric acid, saline
or the local application of antibiotics. Soaking an
implant surface with 3% hydrogen peroxide for
one minute demonstrated inactivation of attached
bacteria.37
Following surface detoxification, local delivery
system using chips were evaluated. Bone
matrix chips (MatrixC) and chlorhexidine chips
(PerioC) were compared for six months in sixty
patients. Following the therapy, patients with
initially deeper probing depth showed a reduction of
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2mm in the PerioC group and 1.59mm in MatrixC
group. Minocycline spheres and chlorhexidine
gel debridement were compared for a year and
showed improvement in plaque indices, pocket
depths and bleeding. Minocycline was shown to
be effective but to maintain the effectiveness,
additional applications might be needed.38,39 Use
of chlorhexidine in humans has been shown to
decrease cell proliferation and reduce collagen
synthesis,40 hence its use in implant surface
detoxification is questioned.
The applications of dental lasers for dental therapy
continue to grow. Laser therapy has been suggested
for management of peri-implantitis due to its antiinfective and ablative properties. Currently lasers
available in the market are: Nd:Yag; carbondioxide;
diode, and Er:Yag. Er:Yag is considered to have the
most potential for management of peri-implantitis.
Along with effective plaque removal, Er:Yag is
not absorbed by the titanium surface and its use
of water irrigation prevents overheating of bone.
Recommended setting for the laser is 100mJ at a
frequency of 10Hz for 2 minutes. Higher settings
can cause implant surface changes.41 Comparative
studies evaluating use of Er:Yag alone in comparison
to surgical and nonsurgical therapy for periimplantitis did not show any additional benefits of
lasers.42 Photodynamic therapy, utilizing 630-700nm
wavelength of light, has shown reduction in clinical
disease parameters for up to six months combined
with application of minocycline.42
Implantoplasty (reshaping and/or smoothing the
implant surface) may be completed with a combination
of diamond and carborundum burs, or carborundum
burs alone.34 The goal of implantoplasty is a smooth
implant surface that enables better maintenance by
the patient and/or the clinician. Implantoplasty may
result in soft tissue loss, creating esthetic concerns
and potentially leading to increased food impaction
in interproximal spaces. Implantoplasty requires
minimal implant surface removal hence implant
weakening does not appear to be an issue. The risks
and benefits of the procedure should be thoroughly
discussed with the patient, explaining the potential
adverse and irreversible outcomes. There is limited
evidence supporting its application and it should
only be employed as an adjunct to other therapeutic
measures.
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Surgical Approaches

A nonsurgical approach is recommended in
shallow defects to maintain the height of the soft
tissue margins.44 Non-surgical therapies, however,
may offer limited access in some regions and
surgical therapy may be necessary to enhance
the opportunity for long-term stabilization. The
surgical technique employed depends on defect
morphology and typically involves an access
flap and debridement/detoxification, followed by
resective and/or regenerative procedures. Schwarz
et al. demonstrated that a combination of resective
and regenerative surgical techniques are usually
more effective.45 Defect morphology can impact the
treatment outcome following regenerative therapy.46
The objective of an access flap and debridement is
to remove the inflamed tissue around the implant,
allowing access to the osseous defect. Implant
surface detoxification, as discussed earlier, can
be achieved using chemical, mechanical and/or
lasers following tissue reflection. In non-esthetic
regions with a shallow, one-walled intrabony defect,
effective therapy consists of implantoplasty and
osteoplasty followed by apically repositioning of the
soft tissue flap. This will result in tissue recession
and a region more conducive to successful
maintenance.
Multiple studies have reported various surgical
approaches based on defect morphology, irrigants,
employing single or multiple grafting materials and,
use of resorbable or non-resorbable membrane.
There is no single surgical therapy that is considered
superior over other. Surgical therapy includes
elevation of mucoperiosteal flap, access to implant
surface and defect by removal of granulation tissue,
implant surface decontamination or modification,
resective or regenerative therapy and post-therapy
systemic antibiotic administration.47 Implant removal
should be considered if they are mobile with
radiographic bone loss extending around the apex.
As surgical therapies are complex procedures, it
is highly recommended that they be performed by
skilled clinicians with surgical training in periodontal
therapies. Also, with no clear evidence supporting
one specific therapy, literature should be reviewed
consistently for strong evidence to support surgical
approaches.

Conclusion

A

number of therapy approaches
have

demonstrated

the

potential to successfully treat

peri-implantitis (Table 2). Techniques for
the management of peri-implantitis are
still evolving. Many protocols have been
tried, with some showing promising clinical
results. However, there is no protocol
proven to be superior over other. At this
time, it appears that research supports the
following conclusions:
1. Peri-implant mucositis acts as a
precursor for peri-implantitis
2. Surface detoxification, along with
modification of the implant and the
tissue

architecture

to

facilitate

maintenance, are the most important
steps in management of all periimplantitis lesions.
3. Lasers do not demonstrate additional
benefit

over

other

detoxification

techniques.
4. Defect morphology dictates type of
surgical approach that should be
utilized.

Table 2 - Therapeutic Options
Non-Surgical

• Surface
detoxification
• Curettes
• Airpowder abrasive

Surgical

• Resective
• Regenerative
• Combination

• Local drug delivery
• Lasers
• Implantoplasty
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POST-TEST
Internet Users: This page is intended to assist you in fast and accurate testing when completing the “Online Exam.”
We suggest reviewing the questions and then circling your answers on this page prior to completing the online exam.
(1.0 CE Credit Contact Hour) Please circle the correct answer. 70% equals passing grade.
1. Peri-implantitis differs from peri-implant mucositis by
a. Deep probing depths
b. Bleeding on probing
c. Loss of supporting bone
d. Swelling around restored implant
2. Identify least potential risk factors in the etiology of
peri-implantitis could be all of the following, EXCEPT:
a. A screw retained implant crown
b. Diabetes
c. Poor oral hygiene
d. Occlusal overload
3. Surface detoxification is common step for surgical and
non-surgical approaches for treating peri-implantitis.
a. True
b. False
4. Implants should be managed for peri-implantitis in all
of the cases, EXCEPT:
a. Near anatomic landmark
b. Key restorative position
c. Intrabony defects
d. Mobility
5. All of the following are true about implantoplasty,
EXCEPT:
a. Compromises esthetics
b. Enables maintenance
c. Stimulates re-osseointegration
d. Results in soft tissue loss

www.metdental.com

6. Selection of a peri-implantitis treatment approach
depends on:
a. Defect morphology
b. Probing depth
c. Radiographic bone loss in relation to implant length
d. All of the abov
7. During surgical management of peri-implantitis,
implants must be always submerged.
a. True
b. False
8. The proposed Er:Yag laser setting for peri-implantitis
management is:
a. 100mJ/10Hz
b. 50mJ/15Hz
c. 120mJ/10Hz
d. 100mJ/20Hz
9. In a defect with less than 4mm probing depth, bleeding
on probing, 10-15% bone loss along the implant
length and systemically healthy patient, the following
is approach to treating peri-implantitis would be
generally recommended:
a. Surgical approach
b. Non-surgical approach
c. Combination of surgical and non-surgical therapy
d. No treatment
10. Access flaps allow:
a. Removal of inflamed tissue around the implant
b. Access to peri-implantitis defect
c. All of the above
d. None of the above
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Providing dentists with the opportunity for continuing dental education is an essential part of MetLife’s commitment to helping dentists improve the oral health of
their patients through education. You can help in this effort by providing feedback regarding the continuing education offering you have just completed.

Please respond to the statements below by checking the appropriate box,
using the scale on the right.

1 = POOR				
1

2

3

4

5 = Excellent
5

1. How well did this course meet its stated educational objectives?
2. How would you rate the quality of the content?
3. Please rate the effectiveness of the author.
4. Please rate the written materials and visual aids used.
5. The use of evidence-based dentistry on the topic when applicable.

N/A

6. How relevant was the course material to your practice?
7. The extent to which the course enhanced your current knowledge or skill?
8. The level to which your personal objectives were satisfied.
9. Please rate the administrative arrangements for this course.
10. How likely are you to recommend MetLife’s CE program to a friend or colleague? (please circle one number below:)
10
		

9

8

extremely likely

7

6

5

4

3

2

neutral

1

0

not likely at all

What is the primary reason for your 0-10 recommendation rating above?
11. Please identify future topics that you would like to see:

Thank you for your time and feedback.
To Complete Program Traditionally, Please Mail Your Post Test and Evaluation Forms To:
MetLife Dental Quality Initiatives Program
501 US Highway 22
Bridgewater, NJ 08807
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